1. Fehr AR, Perlman S. Coronaviruses: an overview of their replicationand pathogenesis. In: Maier HJ, Bickerton E, Britton P, eds.Coronviruses: Methods and Protocols. Humana Press: 2015:1-23. doi:10.1007/978-1-4939-2438-7_1
2. Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Advances Virus Res.2011;81:85-164. doi: 10.1016/B978-0-12-385885-6.00009-2
3. Malik YS, Sircar S, Bhat S, et al. Emerging novel coronavirus (2019-nCoV) current scenario, evolutionary perspective based on genomeanalysis and recent developments. Veterinary Quarterly. 2020;40(1): 68-76. doi: 10.1080/01652176.2020.1727993
4. Cheng ZJ, Shan J. 2019 Novel coronavirus: where we are and what weknow. Infection. 2020;48(2):155-163. doi: 10.1007/s15010-020-01401-y
5. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreakassociated with a new coronavirus of probable bat origin. Nature.2020;579(7798):270-273. doi: 10.1038/s41586-020-2012-7
6. Mao L, Wang M, Chen S, et al. Neurological manifestations ofhospitalized patients with COVID-19 in Vuhan, China: a retrospectivecase series study. MedRxiv. 2020. doi: 10.1101/2020.02.22.20026500
7. Wang L, Shen Y, Li M, et al. Clinical manifestations and evidence ofneurological involvement in 2019 novel coronavirus SARS-CoV-2: asystematic review and meta analysis. J Neurol. 2020;267:2777-2789. doi:10.1007/s00415-020-09974-2
8. Karadaş Ö, Öztürk B, Sonkaya AR. A prospective clinical study ofdetailed neurological manifestations in patients with COVID-19.Neurol Sci. 2020;41(8):1991-1995. doi: 10.1007/s10072-020-04547-7
9. Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis.2020;94:55-58. doi: 10.1016/j.ijid.2020.03.062
10. Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L,Rusconi S, Gervasoni C, Ridolfo AL, Rizzardini G, Antinori S, Galli M.Self-reported olfactory and taste disorders in patients with severe acuterespiratory coronavirus 2 infection: a cross-sectional study. Clin InfectDis. 2020;71(15):889-890. doi: 10.1093/cid/ciaa330.
11. Limphaibool N, Iwanowski P, Holstad MJV, Kobylarek D, Kozubski W.Infectious etiologies of parkinsonism: pathomechanisms and clinicalimplications. Front Neurol. 2019;10:652. doi: 10.3389/fneur.2019.00652
12. Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-convertingenzyme-related carboxypeptidase (ACE2) converts angiotensin I toangiotensin 1-9. Circ Res. 2000;87(5):e1-e9. doi: 10.1161/01.res.87.5.e1
13. Martin D, Xu J, Porretta C, Nichols CD. Neurocytometry: flowcytometric sorting of specific neuronal populations from human androdent brain. ACS Chem Neurosci. 2017;8(2):356-367. doi: 10.1021/acschemneuro.6b00374
14. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19virus targeting the CNS: tissue distribution , host − virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci.2020;11(7):995-998. doi: 10.1021/acschemneuro.0c00122
15. Ding Y, He LI, Zhang Q, et al. Organ distribution of severe acuterespiratory syndrome (SARS) associated coronavirus (SARS-CoV) inSARS patients: implications for pathogenesis and virus transmissionpathways. J Pathol. 2004;203(2):622-630. doi: 10.1002/path.1560
16. Pan W, Stone PK, Hsuchou H, Manda KV, Zhang Y, Kastin, JA.Cytokine signaling modulates blood-brain barrier function. CurrPharm Des. 2011;17(33):3729-3740. doi: 10.2174/138161211798220918
17. Dubé M, Le Coupanec A, Wong AHM, Rini JM, Desforges M, TalbotPJ. Axonal transport enables neuron-to-neuron propagation of humancoronavirus OC43. J Virol. 2018;92(17):e00404-18. doi: 10.1128/JVI.00404-18
18. Desforges M, Le Coupanec A, Dubeau P, et al. Human coronavirusesand other respiratory viruses: underestimated opportunistic pathogensof the central nervous system? Viruses. 2020;12(1):14. doi: 10.3390/v12010014
19. Hughes JM, Wilson ME, Sejvar JJ. The long-term outcomes of humanWest Nile virus infection. Clin Infect Dis. 2007;44(12):1617-1624. doi:10.1086/518281.
20. Jang H, Boltz DA, Webster RG, Smeyne RJ. Viral parkinsonism.Biochimica Biophysica Acta (BBA)-Molecul Basis Dis. 2009;1792(7):714-721. doi: 10.1016/j.bbadis.2008.08.001
21. Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acuterespiratory syndrome coronavirus infection causes neuronal death inthe absence of encephalitis in mice transgenic for human ACE2. J Virol.2008;82(15):7264-7275. doi: 10.1128/JVI.00737-08
22. Fazzini E, Fleming J, Fahn S. Cerebrospinal fluid antibodies tocoronavirus in patients with Parkinson’s disease. Mov Disord.1992;7(2):153-158. doi: 10.1002/mds.870070210
23. Rodriguez-Perez AI, Garrido-Gil P, Pedrosa MA, et al. Angiotensintype 2 receptors: role in aging and neuroinflammation in thesubstantia nigra. Brain Behav Immun. 2020;87:256-271. doi: 10.1016/j.bbi.2019.12.011
24. Arlehamn CSL, Garretti F, Sulzer D, Sette A. Roles for the adaptiveimmune system in Parkinson’s and Alzheimer’s diseases. Curr OpinImmunol. 2019;59:115-120. doi: 10.1016/j.coi.2019.07.004
25. Agrawal U, Raju R, Udwadia ZF. Favipiravir: a new and emergingantiviral option in COVID-19. Med J Armed Forces India.2020;76(4):370-376. doi: 10.1016/j.mjafi.2020.08.004